Mackenzie Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $257M | Buy |
2,033,130
+1,015,911
| +100% | +$134M | 0.26% | 74 |
|
|
2026
Q1 | $142M | Sell |
1,017,219
-761,326
| -43% | -$107M | 0.17% | 119 |
|
|
2025
Q4 | $219M | Sell |
1,778,545
-285,379
| -14% | -$34.7M | 0.26% | 86 |
|
|
2025
Q3 | $229M | Sell |
2,063,924
-464,125
| -18% | -$52.8M | 0.28% | 81 |
|
|
2025
Q2 | $280M | Buy |
2,528,049
+27,840
| +1% | +$2.96M | 0.36% | 69 |
|
|
2025
Q1 | $280M | Buy |
2,500,209
+1,939,273
| +346% | +$200M | 0.4% | 67 |
|
|
2024
Q4 | $51.8M | Sell |
560,936
-45,294
| -7% | -$4.08M | 0.07% | 217 |
|
|
2024
Q3 | $50.8M | Sell |
606,230
-12,772
| -2% | -$975K | 0.07% | 223 |
|
|
2024
Q2 | $42.5M | Buy |
619,002
+77,337
| +14% | +$5.16M | 0.06% | 234 |
|
|
2024
Q1 | $39.7M | Buy |
541,665
+6,108
| +1% | +$470K | 0.06% | 240 |
|
|
2023
Q4 | $43.4M | Buy |
535,557
+43,630
| +9% | +$3.4M | 0.07% | 230 |
|
|
2023
Q3 | $36M | Buy |
491,927
+13,090
| +3% | +$1.01M | 0.06% | 237 |
|
|
2023
Q2 | $36.7M | Buy |
478,837
+74,710
| +18% | +$5.96M | 0.06% | 247 |
|
|
2023
Q1 | $33.5M | Sell |
404,127
-77,024
| -16% | -$6.38M | 0.05% | 266 |
|
|
2022
Q4 | $41.3M | Sell |
481,151
-116,844
| -20% | -$9.25M | 0.07% | 229 |
|
|
2022
Q3 | $36.9M | Buy |
597,995
+8,761
| +1% | +$552K | 0.06% | 238 |
|
|
2022
Q2 | $36.4M | Buy |
589,234
+26,673
| +5% | +$1.65M | 0.06% | 250 |
|
|
2022
Q1 | $33.4M | Buy |
562,561
+32,327
| +6% | +$2.07M | 0.04% | 275 |
|
|
2021
Q4 | $38.5M | Buy |
530,234
+23,035
| +5% | +$1.59M | 0.05% | 269 |
|
|
2021
Q3 | $35.4M | Buy |
507,199
+71,189
| +16% | +$5M | 0.05% | 270 |
|
|
2021
Q2 | $30M | Buy |
436,010
+22,080
| +5% | +$1.47M | 0.04% | 281 |
|
|
2021
Q1 | $26.8M | Buy |
413,930
+215,664
| +109% | +$13.9M | 0.04% | 279 |
|
|
2020
Q4 | $11.6M | Buy |
198,266
+65,296
| +49% | +$3.94M | 0.02% | 330 |
|
|
2020
Q3 | $8.4M | Sell |
132,970
-59,026
| -31% | -$4.09M | 0.02% | 329 |
|
|
2020
Q2 | $14.8M | Buy |
191,996
+16,800
| +10% | +$1.29M | 0.04% | 255 |
|
|
2020
Q1 | $13.1M | Sell |
175,196
-213,223
| -55% | -$14.7M | 0.04% | 245 |
|
|
2019
Q4 | $25.2M | Sell |
388,419
-88,055
| -18% | -$5.73M | 0.06% | 227 |
|
|
2019
Q3 | $30.2M | Buy |
476,474
+269,974
| +131% | +$17.6M | 0.08% | 208 |
|
|
2019
Q2 | $14M | Sell |
206,500
-239,441
| -54% | -$15.8M | 0.04% | 277 |
|
|
2019
Q1 | $29M | Sell |
445,941
-81,447
| -15% | -$5.41M | 0.07% | 228 |
|
|
2018
Q4 | $33M | Sell |
527,388
-98,354
| -16% | -$6.87M | 0.09% | 197 |
|
|
2018
Q3 | $48.3M | Sell |
625,742
-121,729
| -16% | -$9.19M | 0.12% | 171 |
|
|
2018
Q2 | $53M | Buy |
747,471
+203,371
| +37% | +$14.4M | 0.14% | 161 |
|
|
2018
Q1 | $41M | Sell |
544,100
-213,308
| -28% | -$17M | 0.1% | 175 |
|
|
2017
Q4 | $54.3M | Buy |
757,408
+312,671
| +70% | +$23.7M | 0.13% | 155 |
|
|
2017
Q3 | $36M | Sell |
444,737
-3,987
| -0.9% | -$305K | 0.19% | 138 |
|
|
2017
Q2 | $31.8M | Buy |
448,724
+178,023
| +66% | +$11.8M | 0.18% | 147 |
|
|
2017
Q1 | $18.4M | Sell |
270,701
-6,669
| -2% | -$469K | 0.11% | 190 |
|
|
2016
Q4 | $19.9M | Buy |
277,370
+3,831
| +1% | +$285K | 0.12% | 171 |
|
|
2016
Q3 | $21.6M | Sell |
273,539
-180,013
| -40% | -$14.6M | 0.14% | 154 |
|
|
2016
Q2 | $37.8M | Buy |
453,552
+82,637
| +22% | +$7.33M | 0.21% | 122 |
|
|
2016
Q1 | $34.1M | Buy |
370,915
+23,865
| +7% | +$2.15M | 0.31% | 84 |
|
|
2015
Q4 | $35.1M | Buy |
347,050
+74,498
| +27% | +$7.75M | 0.22% | 109 |
|
|
2015
Q3 | $26.8M | Sell |
272,552
-17,318
| -6% | -$1.92M | 0.16% | 136 |
|
|
2015
Q2 | $33.9M | Sell |
289,870
-29,582
| -9% | -$3.23M | 0.18% | 133 |
|
|
2015
Q1 | $31.3M | Sell |
319,452
-13,540
| -4% | -$1.37M | 0.17% | 145 |
|
|
2014
Q4 | $31.4M | Buy |
332,992
+89,707
| +37% | +$9.28M | 0.16% | 131 |
|
|
2014
Q3 | $25.9M | Sell |
243,285
-290,329
| -54% | -$28.4M | 0.13% | 147 |
|
|
2014
Q2 | $44.2M | Sell |
533,614
-81,144
| -13% | -$6.32M | 0.21% | 108 |
|
|
2014
Q1 | $43.6M | Buy |
614,758
+197,775
| +47% | +$15.5M | 0.21% | 108 |
|
|
2013
Q4 | $31.3M | Sell |
416,983
-192,358
| -32% | -$13.4M | 0.16% | 140 |
|
|
2013
Q3 | $38.3M | Sell |
609,341
-123,905
| -17% | -$7.41M | 0.19% | 121 |
|
|
2013
Q2 | $37.6M | Buy |
+733,246
| New | +$38.2M | 0.18% | 137 |
|
Other funds holding GILD
Mackenzie Financial's GILD Position: Q2 2026 in Review
Mackenzie Financial increased its Gilead Sciences (GILD) stake by 100% in Q2 2026, buying an estimated $134M and bringing the position to 2,033,130 shares worth $257M. The position accounts for 0.26% of the portfolio, ranked #74.
Mackenzie Financial first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $280M in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Mackenzie Financial held 2,033,130 shares of Gilead Sciences worth $257M as of Q2 2026.
- Mackenzie Financial bought 1,015,911 Gilead Sciences shares in Q2 2026, an estimated $134M.
- Gilead Sciences made up 0.26% of Mackenzie Financial's portfolio in Q2 2026, its #74 holding.
- Mackenzie Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Mackenzie Financial's Gilead Sciences position peaked at $280M in Q2 2025.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.